Pediatric Cancer Care

Blood & Marrow Transplantation: Our Clinical Trials

Browse a list of Memorial Sloan-Kettering’s clinical trials for blood and marrow transplantation that are currently enrolling patients.

Showing 16 trials

Title	Investigator
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies [Protocol 06-066]	Barker, Juliet, MBBS
A Phase I Study of Donor T Cells Sensitized with Pentadecapeptides of the CMV-PP65 Protein for the Treatment of CMV Infections Following Allogeneic Hematopoietic Stem Cell Transplants [Protocol 05-065]	O'Reilly, Richard, MD
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders [Protocol 95-024]	O'Reilly, Richard, MD
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies [Protocol 06-125]	Boulad, Farid, MD
A Phase II Pilot Trial of Hematopoietic Stem Cell Transplantation with Total Body Irradiation, Cyclophosphamide & Fludarabine to Treat Patients with Fanconi Anemia Lacking a Genotypically Identical Donor [Protocol 01-062]	Boulad, Farid, MD
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS [Protocol 08-008]	Castro-Malaspina, Hugo, MD
A Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients with Fanconi Anemia [Protocol 08-031]	Boulad, Farid, MD
A Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant [Protocol 07-035]	Hsu, Katharine, MD, PhD
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders [Protocol 10-050]	O'Reilly, Richard, MD
A Phase II/III Study of Sirolimus plus Prednisone, Sirolimus/Extracorporeal Photopheresis plus Prednisone, and Sirolimus/Calcineurin Inhibitor plus Prednisone for the Treatment of Chronic Graft-versus-Host-Disease [Protocol 10-201]	Goldberg, Jenna, MD
A Prospective Natural History Study of the Diagnosis, Treatment, and Outcomes of Children with SCID Disorders [Protocol 10-150]	O'Reilly, Richard, MD
A Study of CMX001 Treatment for Serious Infections Caused by dsDNA Viruses [Protocol 10-169]	Papanicolaou, Genovefa, MD
Cyclophosphamide, Fludarabine, and Total Body Irradiation Followed by the Transplantation of Unrelated Double-Unit Donor Umbilical Cord Blood Grafts for Patients with Hematological Malignancy [Protocol 06-014]	Barker, Juliet, MBBS
Defibrotide for Patients with Hepatic Veno-Occlusive Disease [Protocol 08-060]	Kernan, Nancy, MD
Expanded Access of Prochymal Infusion for the Treatment of Pediatric Patients with Acute Refractory GVHD [Protocol 09-072]	Prockop, Susan, MD
Phase II Prospective Clinical Trial of Vaccine Responses in Childhood Survivors of Cancer Who Had Chemotherapy [Protocol 07-088]	Small, Trudy, MD